Bansal AS - Search Results

1

THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.

Khurana RN, Wykoff CC, Bansal AS, Akiyama K, Palmer JD, Chen E, Chang LK, Major JC Jr, Wu C, Wang R, Croft DE, Wong TP. Khurana RN, et al. Among authors: bansal as. Retina. 2017 Jun;37(6):1073-1078. doi: 10.1097/IAE.0000000000001307. Retina. 2017. PMID: 27632712

2

Peripheral retinal findings in highly myopic children < or =10 years of age.

Bansal AS, Hubbard GB 3rd. Bansal AS, et al. Retina. 2010 Apr;30(4 Suppl):S15-9. doi: 10.1097/IAE.0b013e3181cf5c80. Retina. 2010. PMID: 20224463 Free PMC article.

3

Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factors.

Bansal AS, Hsu J, Garg SJ, Sivalingam A, Vander JF, Moster M, Maguire JI, Regillo CD. Bansal AS, et al. Ophthalmology. 2012 Nov;119(11):2364-70. doi: 10.1016/j.ophtha.2012.06.002. Epub 2012 Jul 26. Ophthalmology. 2012. PMID: 22840420

4

Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema: A Post Hoc Analysis of the RIDE/RISE Trials.

Bansal AS, Khurana RN, Wieland MR, Wang PW, Van Everen SA, Tuomi L. Bansal AS, et al. Ophthalmology. 2015 Aug;122(8):1573-9. doi: 10.1016/j.ophtha.2015.04.029. Epub 2015 Jun 4. Ophthalmology. 2015. PMID: 26050541 Free article. Clinical Trial.

5

Fluorescein-Assisted Subretinal Tissue Plasminogen Activator (tPA) Delivery For Submacular Hemorrhage.

Khan MA, Shahlaee A, Bansal AS, Maguire JI. Khan MA, et al. Among authors: bansal as. Retina. 2017 Jun;37(6):1203-1206. doi: 10.1097/IAE.0000000000001349. Retina. 2017. PMID: 27755377 No abstract available.

6

PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.

Khurana RN, Bansal AS, Chang LK, Palmer JD, Wu C, Wieland MR. Khurana RN, et al. Among authors: bansal as. Retina. 2017 Sep;37(9):1692-1699. doi: 10.1097/IAE.0000000000001406. Retina. 2017. PMID: 27893624

7

Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study.

Khurana RN, Chang LK, Bansal AS, Palmer JD, Wu C, Wieland MR. Khurana RN, et al. Among authors: bansal as. Int J Retina Vitreous. 2019 Apr 15;5:10. doi: 10.1186/s40942-019-0159-x. eCollection 2019. Int J Retina Vitreous. 2019. PMID: 31016030 Free PMC article.

8

Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.

Khurana RN, Chang LK, Bansal AS, Palmer JD, Wu C, Wieland MR. Khurana RN, et al. Among authors: bansal as. Ophthalmol Retina. 2018 Feb;2(2):128-133. doi: 10.1016/j.oret.2017.05.017. Epub 2017 Oct 12. Ophthalmol Retina. 2018. PMID: 31047339 Clinical Trial.

9

Reply.

Khurana RN, Chang LK, Bansal AS. Khurana RN, et al. Among authors: bansal as. Ophthalmol Retina. 2018 Mar;2(3):e6. doi: 10.1016/j.oret.2017.11.015. Epub 2018 Jan 10. Ophthalmol Retina. 2018. PMID: 31047598 No abstract available.

10

Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.

Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters